Ensuring Safety in Gene-Edited iPSC Therapies to Accelerate Development of Next-Generation Treatments
Time: 12:15 pm
day: Day Two Track A AM
Details:
- Focusing on methods for maintaining genomic stability and minimizing mosaicism after gene editing in iPSCs, promoting safety
- Developing new genomic stability testing methods to ensure the safety of iPSC-derived cell therapies
